Norman Noble Announces Expansion of Operations.

Additional facility will support growing demand for the manufacturing of nitinol implants.

HIGHLAND HEIGHTS, OHIO – July 27, 2020 – Norman Noble, Inc., a medical device contract manufacturer, today announced it has begun improvements on a new 50,000-square-foot facility in Highland Heights, Ohio. The new facility will provide additional manufacturing space to meet medical OEM customers’ growing requirements for products, including nitinol-based structural heart implants and neurovascular devices as well as multileaf collimator (MLC) assemblies used in cancer radiation therapy equipment. The new facility is scheduled to be operational in Q4-2020.

Norman Noble COO Chris Noble explained that “the additional facility is needed to support demand growth for next-gen products. The additional space will also provide our customers with production surge capacity. We are very excited to grow our facilities and expand our team of highly skilled associates as we continue to strengthen our partnerships with the world’s largest medical companies”.

Med3 Facility - Neurovascular Devices


Download our Expansion of Operations Press Release.